Advertisement
Screener

ORGANOGENESIS HOLDINGS INC. (ORGO) Graph

ORGO Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2015-12-31: Operating expenses $25.16K; Net income -$25.16K.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ORGO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Grant$950.00KProduct$42.80MRevenue$43.76MOperating expenses$94.75MOperating income-$50.99MOther income, net-$26.00KResearch & development$18.30MSelling, general& administrative$53.96MPre-tax income-$50.88MIncome tax$45.39MNet income-$96.27M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 1 month

Period endOperating expensesNet income
2015-12-31$25.16K-$25.16K

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$43.76M(m)$18.30M$53.97M$94.75M$45.39M-$96.27M
2026-03-31$37.23M(m)$15.16M$65.19M$106.12M-$15.32M-$53.16M
2025-12-31$225.61M*(m)$10.29M*$100.17M*$162.32M*$19.73M*$43.67M*
2025-09-30$150.86M(m)$13.22M$79.74M$130.14M-$407.00K$21.57M
2025-06-30$101.00M(m)$10.39M$73.81M$113.58M-$2.44M-$9.39M
2025-03-31$86.69M$23.72M$10.64M$72.51M$113.44M-$6.94M-$18.84M
2024-12-31(m)$31.05M*(m)(m)(m)(m)(m)
2024-09-30$115.18M$26.80M$10.34M$71.80M$108.94M-$6.51M$12.33M
2024-06-30$130.23M$29.20M$15.59M$76.54M$144.13M$2.50M-$17.04M
2024-03-31$109.98M$28.70M$12.81M$72.32M$85.13M-$2.24M-$2.10M
2023-09-30$108.53M$25.79M$10.47M$64.22M$74.69M$4.47M$3.17M
2023-06-30$117.32M$26.32M$10.94M$70.32M$81.25M$3.86M$5.32M
2023-03-31$107.64M$26.61M$11.20M$73.83M$85.04M-$1.66M-$2.97M
2022-09-30$116.86M$26.18M$9.57M$79.33M$88.90M$997.00K$215.00K
2022-06-30$121.40M$26.65M$10.21M$72.61M$82.81M$2.44M$8.74M
2022-03-31$97.12M$25.08M$8.59M$63.58M$72.17M$45.00K-$913.00K
2021-09-30$113.75M$26.17M$8.95M$62.37M$71.32M$303.00K$12.58M
2021-06-30$123.20M$29.94M$7.32M$62.35M$69.67M$487.00K$20.69M
2021-03-31$102.55M$25.50M$6.21M$58.23M$64.44M$200.00K$9.94M
2020-09-30$100.80M$22.96M$3.71M$51.33M$55.03M$72.00K$20.75M
2020-06-30$68.96M$20.04M$4.67M$46.50M$51.17M$27.00K-$5.17M
2020-03-31$61.73M$18.79M$5.41M$52.61M$58.02M$35.00K-$16.31M
2019-09-30$64.27M$19.13M$3.92M$49.48M$53.40M$48.00K-$10.74M
2019-06-30$64.95M$19.45M$3.86M$48.96M$52.82M$23.00K-$9.65M
2019-03-31$57.12M$16.98M$3.37M$48.89M$52.26M$37.00K-$15.67M
2018-12-31$63.60M$17.51M$3.09M$47.48M(m)$2.00K-$9.26M
2018-09-30$50.77M$19.48M$2.78M$38.58M$41.36M$27.00K-$13.08M
2018-06-30$43.55M$17.30M$2.05M$37.73M$43.28M$27.00K-$20.01M
2018-03-31$35.53M$14.52M$2.82M$38.16M$40.99M$28.00K-$22.49M
2017-12-31$53.14M$16.42M$2.73M$36.39M$1.30M-$233.00K-$4.43M
2017-09-30$51.46M$16.09M$2.33M$35.66M$2.85M$47.00K-$5.40M
2017-06-30$54.07M$15.41M$2.45M$33.72M$221.81K-$156.00K$31.00K
2017-03-31$39.84M$13.30M$1.55M$27.95M$218.65K-$6.68M$2.27M
2016-12-31(m)(m)(m)(m)$178.16K(m)-$178.16K
2016-09-30(m)(m)(m)(m)$14.49K(m)-$14.49K
2016-06-30(m)(m)(m)(m)$500.00(m)-$500.00
2016-03-31(m)(m)(m)(m)$15.55K(m)-$15.55K

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$80.98M(m)$33.46M$119.15M$200.87M$30.07M-$149.42M
2025-06-30$187.70M(m)$21.04M$146.32M$227.02M-$9.38M-$28.23M
2024-06-30$240.21M$57.89M$28.40M$148.86M$257.95M$260.00K-$19.14M
2023-06-30$224.96M$52.92M$22.14M$144.15M$166.29M$2.21M$2.35M
2022-06-30$218.52M$51.73M$18.79M$136.19M$154.98M$2.48M$7.83M
2021-06-30$225.75M$55.44M$13.53M$120.58M$134.11M$687.00K$30.63M
2020-06-30$130.69M$38.84M$10.08M$99.11M$109.19M$62.00K-$21.48M
2019-06-30$122.07M$36.43M$7.24M$97.85M$105.08M$60.00K-$25.32M
2018-06-30$79.08M$31.82M$4.87M$75.90M$84.27M$55.00K$221.34K
2017-06-30$0.00(m)(m)(m)$440.46K(m)$521.20K
2016-06-30(m)(m)(m)(m)$16.05K(m)-$16.05K

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$338.56M(m)$34.26M$226.06M$357.16M-$9.79M-$6.67M
2024-09-30$355.39M$84.69M$38.74M$220.66M$366.89M-$6.25M-$6.81M
2023-09-30$333.49M$78.71M$32.61M$208.37M$240.98M$6.67M$5.51M
2022-09-30$335.38M$77.91M$28.37M$215.51M$243.88M$3.48M$8.05M
2021-09-30$339.50M$81.60M$22.48M$182.95M$205.43M$990.00K$43.21M
2020-09-30$231.49M$61.80M$13.79M$150.80M$164.58M$134.00K-$1.08M
2019-09-30$186.34M$55.56M$11.16M$147.32M$158.48M$108.00K-$36.06M
2018-09-30$129.85M$51.30M$7.65M$114.48M$125.63M$82.00K-$55.58M
2017-09-30$0.00(m)(m)(m)$3.29M(m)-$1.60M
2016-09-30$0.00(m)(m)(m)$30.54K(m)-$30.54K

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$564.17M(m)$44.54M$326.24M$519.48M$9.94M$37.00M
2024-12-31$482.04M$115.74M$50.27M$294.51M$483.33M-$3.67M$900.00K
2023-12-31$433.14M$106.48M$44.38M$269.75M$420.62M$5.45M$4.90M
2022-12-31$450.89M$105.02M$39.76M$283.81M$323.57M$4.75M$15.50M
2021-12-31$467.36M$114.20M$30.74M$250.20M$280.94M-$31.12M$94.20M
2020-12-31$338.30M$87.32M$20.09M$204.19M$224.28M$530.00K$17.23M
2019-12-31$260.98M$75.95M$14.80M$200.09M$214.89M$150.00K-$38.71M
2018-12-31$193.45M$68.81M$10.74M$161.96M$176.20M$84.00K-$64.83M
2017-12-31$198.51M$61.22M$9.06M$133.72M$142.78M-$7.03M-$8.39M
2016-12-31$138.73M$48.20M$6.28M$93.03M$99.31M$65.00K-$16.99M

Similar stocks

Stock NameCountryMarket CapPE Ratio
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
PepGen Inc. (PEPG)United States$0.186B-1.73
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
ADC Therapeutics SA (ADCT)$0.163B-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)United States$0.163B-8.50